NCT00635856View on ClinicalTrials.gov

Open Label Trial to Assess Iressa in Prostate Cancer Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

May 31, 2001

Study Completion Date

February 28, 2003

Conditions

Prostate Cancer

Interventions

DRUG

Gefitinib

Iressa

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY